MYO1C and neoplasm: These outcomes are additional supporting evidences for the proposed tumor suppressor characteristic of MYO1C. Finally, we found that the MYO1C protein level was reduced in endometrial carcinomas and that this reduced expression was significantly different between tumors and hyperplasia samples.